Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2022

Open Access 30-08-2022 | Contraception | Original Research

Oral Emergency Contraception Provision in the Veterans Health Administration: a Retrospective Cohort Study

Authors: Lori M. Gawron, MD, MPH, Tao He, MS, Lacey Lewis, MPH, Hannah Fudin, PharmD, Lisa S. Callegari, MD, MPH, David K. Turok, MD, MPH, Vanessa Stevens, PhD

Published in: Journal of General Internal Medicine | Special Issue 3/2022

Login to get access

ABSTRACT

Background

In the USA, oral emergency contraception (EC) use to prevent unintended pregnancy is increasing. Oral EC methods include levonorgestrel (LNG) and ulipristal acetate (UPA), with increased UPA efficacy over LNG in high BMI users and those beyond 3 days post intercourse. The Veterans Health Administration (VHA) provides oral EC at low or no cost, yet prescription-level Veteran data are lacking.

Objective

To describe oral EC provision in VHA, including method type and Veteran user and prescriber characteristics.

Design

A retrospective cohort study using VHA administrative data.

Participants

All VHA oral EC prescriptions from January 1, 2016, to December 31, 2020.

Main Measures

We linked Veteran-level sociodemographic and military characteristics and provider-level data with each prescription to identify variables associated with oral EC method.

Key Results

A total of 4280 EC prescriptions (85% LNG) occurred for 3120 unique Veterans over 5 years. While prescriptions remained low annually, the proportion of UPA prescriptions increased from 12 to 19%. Compared to LNG users, UPA users were older (34% vs 25% over age 35 years, p <0.001); more likely to identify as white (57% vs 46%) and non-Hispanic (84% vs 79%) (p <0.001); and more likely to have a BMI ≥ 25 (76% vs 67%, p <0.001). UPA prescriptions originated most frequently from VA Medical Centers (87%) and women’s health clinics (76%) compared to community-based or other clinic types. In multivariable regression models, race, ethnicity, BMI ≥30, and prescriber facility type of a VA Medical Center or a women’s clinic location were predictive of UPA prescription.

Conclusions

Oral EC provision in VHA remains low, but UPA use is increasing. LNG prescription occurs frequently in high BMI Veterans who would benefit from increased efficacy of UPA. Interventions to expand oral EC access in VHA are essential to ensure Veterans’ ability to avert unwanted pregnancies.
Literature
3.
go back to reference Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(RR-4):1-66.PubMed Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(RR-4):1-66.PubMed
4.
go back to reference Glasier A, Cameron ST, Blithe D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception. 2011;84(4):363-367.CrossRef Glasier A, Cameron ST, Blithe D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception. 2011;84(4):363-367.CrossRef
5.
go back to reference Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555-562.CrossRef Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555-562.CrossRef
6.
go back to reference French VA, Mattingly TL, Rangel AV, Shelton AU. Availability of ulipristal acetate: A secret shopper survey of pharmacies in a metropolitan area on emergency contraception. J Am Pharm Assoc. 2003;2019;59(6):832-835. French VA, Mattingly TL, Rangel AV, Shelton AU. Availability of ulipristal acetate: A secret shopper survey of pharmacies in a metropolitan area on emergency contraception. J Am Pharm Assoc. 2003;2019;59(6):832-835.
7.
go back to reference Kaur G, Fontanilla T, Bullock H, Tschann M. "The Difference between Plan b and ella(R)? They're Basically the Same Thing": Results from a Mystery Client Study. Pharmacy. 2020;8(2). Kaur G, Fontanilla T, Bullock H, Tschann M. "The Difference between Plan b and ella(R)? They're Basically the Same Thing": Results from a Mystery Client Study. Pharmacy. 2020;8(2).
8.
go back to reference Milkowski CM, Ziller EC, Ahrens KA. Rural-urban residence and emergency contraception use, access, and counseling in the United States, 2006-2017. Contracept X. 2021;3:100061.CrossRef Milkowski CM, Ziller EC, Ahrens KA. Rural-urban residence and emergency contraception use, access, and counseling in the United States, 2006-2017. Contracept X. 2021;3:100061.CrossRef
9.
go back to reference Schwarz EB, Sileanu FE, Zhao X, Mor MK, Callegari LS, Borrero S. Induced abortion among women veterans: data from the ECUUN study. Contraception. 2017;97(1):41-47.CrossRef Schwarz EB, Sileanu FE, Zhao X, Mor MK, Callegari LS, Borrero S. Induced abortion among women veterans: data from the ECUUN study. Contraception. 2017;97(1):41-47.CrossRef
10.
go back to reference Quinn DA, Sileanu FE, Zhao X, et al. History of unintended pregnancy and patterns of contraceptive use among racial and ethnic minority women veterans. Am J Obstet Gynecol. 2020;223(4):564 e561-564 e513.CrossRef Quinn DA, Sileanu FE, Zhao X, et al. History of unintended pregnancy and patterns of contraceptive use among racial and ethnic minority women veterans. Am J Obstet Gynecol. 2020;223(4):564 e561-564 e513.CrossRef
11.
go back to reference Callegari LS, Zhao X, Nelson KM, Borrero S. Contraceptive adherence among women Veterans with mental illness and substance use disorder. Contraception. 2015;91(5):386-392.CrossRef Callegari LS, Zhao X, Nelson KM, Borrero S. Contraceptive adherence among women Veterans with mental illness and substance use disorder. Contraception. 2015;91(5):386-392.CrossRef
12.
go back to reference MacDonald S, Hausmann LRM, Sileanu FE, Zhao X, Mor MK, Borrero S. Associations Between Perceived Race-based Discrimination and Contraceptive Use Among Women Veterans in the ECUUN Study. Med Care. 2017;55 Suppl 9 Suppl 2:S43-S49.CrossRef MacDonald S, Hausmann LRM, Sileanu FE, Zhao X, Mor MK, Borrero S. Associations Between Perceived Race-based Discrimination and Contraceptive Use Among Women Veterans in the ECUUN Study. Med Care. 2017;55 Suppl 9 Suppl 2:S43-S49.CrossRef
14.
go back to reference Goyal V, Mattocks K, Bimla Schwarz E, et al. Contraceptive provision in the VA healthcare system to women who report military sexual trauma. J Womens Health. 2014;23(9):740-745.CrossRef Goyal V, Mattocks K, Bimla Schwarz E, et al. Contraceptive provision in the VA healthcare system to women who report military sexual trauma. J Womens Health. 2014;23(9):740-745.CrossRef
15.
go back to reference Borrero S, Callegari LS, Zhao X, et al. Unintended Pregnancy and Contraceptive Use Among Women Veterans: The ECUUN Study. J Gen Intern Medicine. 2017;32(8):900-908.CrossRef Borrero S, Callegari LS, Zhao X, et al. Unintended Pregnancy and Contraceptive Use Among Women Veterans: The ECUUN Study. J Gen Intern Medicine. 2017;32(8):900-908.CrossRef
16.
go back to reference Frayne SM, Phibbs CS, Saechao F, et al. Sourcebook: Women Veterans in the Veterans Health Administration. Volume 4. Longitudinal Trends in Sociodemographics, Utilization, Health Profile and Geographic Distribution. Women’s Health Evaluation Initiative, Women’s Health Services, Veterans Health Administration, Department of Veterans Affairs, Washington DC. Frayne SM, Phibbs CS, Saechao F, et al. Sourcebook: Women Veterans in the Veterans Health Administration. Volume 4. Longitudinal Trends in Sociodemographics, Utilization, Health Profile and Geographic Distribution. Women’s Health Evaluation Initiative, Women’s Health Services, Veterans Health Administration, Department of Veterans Affairs, Washington DC.
17.
go back to reference Rodriguez MI, Curtis KM, Gaffield ML, Jackson E, Kapp N. Advance supply of emergency contraception: a systematic review. Contraception. 2013;87(5):590-601.CrossRef Rodriguez MI, Curtis KM, Gaffield ML, Jackson E, Kapp N. Advance supply of emergency contraception: a systematic review. Contraception. 2013;87(5):590-601.CrossRef
18.
go back to reference Gawron LM, Turok DK. Pills on the World Wide Web: reducing barriers through technology. Am J Obstet Gynecol. 2015;213(4):500 e501-504. Gawron LM, Turok DK. Pills on the World Wide Web: reducing barriers through technology. Am J Obstet Gynecol. 2015;213(4):500 e501-504.
19.
go back to reference Stone RH, Rafie S, Ernest D, Scutt B. Emergency Contraception Access and Counseling in Urban Pharmacies: A Comparison between States with and without Pharmacist Prescribing. Pharmacy. 2020;8(2). Stone RH, Rafie S, Ernest D, Scutt B. Emergency Contraception Access and Counseling in Urban Pharmacies: A Comparison between States with and without Pharmacist Prescribing. Pharmacy. 2020;8(2).
20.
go back to reference Garbers S, Bell DL, Ogaye K, Marcell AV, Westhoff CL, Rosenthal SL. Advance provision of emergency contraception to young men: An exploratory study in a clinic setting. Contraception. 2018. Garbers S, Bell DL, Ogaye K, Marcell AV, Westhoff CL, Rosenthal SL. Advance provision of emergency contraception to young men: An exploratory study in a clinic setting. Contraception. 2018.
Metadata
Title
Oral Emergency Contraception Provision in the Veterans Health Administration: a Retrospective Cohort Study
Authors
Lori M. Gawron, MD, MPH
Tao He, MS
Lacey Lewis, MPH
Hannah Fudin, PharmD
Lisa S. Callegari, MD, MPH
David K. Turok, MD, MPH
Vanessa Stevens, PhD
Publication date
30-08-2022
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue Special Issue 3/2022
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-022-07596-0

Other articles of this Special Issue 3/2022

Journal of General Internal Medicine 3/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.